HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: HLA-B*5701 And Hypersensitivity To Abacavir
An update on a clinical trial investigating whether HLA-B*57:01 genotype status predicts hypersensitivity to abacavir in HIV-infected indivi…
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects [Phase 3]
Phase 3 trial of CCR5 antagonist GW873140 in treatment-experienced HIV-infected subjects was terminated.
-
CLINICAL_TRIALS withdrawal · 2009-05-18Clinical Trial Update: Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
An observational study of HIV-infected subjects with X4-tropic or non-phenotypeable virus has been terminated.
-
CLINICAL_TRIALS research · 2009-05-15Clinical Trial Update: Cognitive and Psychosocial Benefits of MISC Training for Ugandan Children [NA]
Sponsor Makerere University reports on a clinical trial exploring cognitive and psychosocial benefits of MISC training for Ugandan children.…
-
FDA approval · 2009-05-13FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine (AZT) from Aurobindo Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-05-13FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine from Aurobindo Pharma Limited, authorizing changes under the approved generic product…
-
FDA approval · 2009-05-08FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine from Aurobindo Pharma Limited, authorizing the marketing of a generic Zidovudine prod…
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally [Phase 1]
This Phase 1 trial assessed the safety and acceptability of UC-781 rectal microbicide gel for HIV prevention and has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-30Clinical Trial Update: Effect of Male Circumcision on HIV Incidence (ANRS 1265) [Phase 3]
Terminated Phase 3 trial ANRS 1265 evaluating whether male circumcision reduces HIV incidence.
-
FDA approval · 2009-04-20FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
FDA approval · 2009-04-20FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2009-04-08Clinical Trial Update: Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection [Phase 1]
Phase 1 clinical trial evaluating an autologous dendritic cell vaccine pulsed with HIV antigens for chronic HIV infection. The study has com…
-
FDA approval · 2009-04-06FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
FDA approval · 2009-04-06FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Kaletra (lopinavir/ritonavir) submitted by AbbVie Inc. The document indicates the submission…
-
CLINICAL_TRIALS trial_result · 2009-04-02Clinical Trial Update: Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy [Phase 4]
A Phase 4 trial comparing immediate versus deferred injections of poly-L-lactic acid for HIV-associated facial lipoatrophy was terminated.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance [Phase 4]
Phase 4 study comparing Truvada (tenofovir disoproxil fumarate + emtricitabine) or emtricitabine alone versus HAART interruption in HIV-infe…
-
CLINICAL_TRIALS research · 2009-03-31Clinical Trial Update: Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients [Phase 4]
This entry describes a Phase 4 clinical trial from Peking Union Medical College testing antiviral therapy and immune reconstitution in Chine…
-
CLINICAL_TRIALS trial_result · 2009-03-30Clinical Trial Update: Effect of Omacor on Triglycerides in HIV Infected Subjects [Phase 4]
This Phase 4 trial update reports the terminated study evaluating Omacor on triglyceride levels in HIV-infected subjects with hypertriglycer…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels [Phase 1]
This clinical trial update reports the completion of a Phase I pharmacokinetics and safety study evaluating two dapivirine intravaginal gels…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: HIV Assessment in Fuyang, Anhui Province, China
This clinical trial conducted in Fuyang, Anhui Province, China studied HIV infections and has completed the study.
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China [NA]
This entry documents a completed cluster-randomized trial in Anhui, China aimed at improving quality of life for HIV-infected individuals.
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya [NA]
Completed trial evaluating the impact of food supplementation on malnourished adults infected with HIV in Kenya.
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Arginine as an Adjuvant Treatment Against Tuberculosis [NA]
This entry notes the completed status of a clinical trial evaluating arginine as an adjunct treatment for tuberculosis, including participan…
-
FDA approval · 2009-03-05FDA Approved: ZIDOVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Zidovudine from Camber Pharmaceuticals, Inc., enabling a generic version to be marketed. Thi…
-
CLINICAL_TRIALS trial_result · 2009-03-05Clinical Trial Update: Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide [Phase 1]
Phase I study evaluating the safety and persistence of the UC-781 vaginal microbicide for HIV prevention has been completed.